DataLockPatientRecruitmentDouble-BlindStudySurrogateEndpointInformedConsentAuditTrailInstitutionalReviewBoard(IRB)CaseReportForm(CRF)PrincipalInvestigatorEfficacyFollow-up VisitDropoutRateData SafetyMonitoringBoard(DSMB)EligibilityCriteriaPilotStudyTrialMonitorAdaptiveDesignControlGroupStatisticalAnalysisPlan(SAP)GoodClinicalPractice(GCP)ProtocolDeviationPhaseIIIBlindingOpen-LabelTrialRegulatoryAuthorityPhaseIRandomizationSponsorCrossoverStudyPlaceboPhaseIIInterventionStandardOperatingProcedure(SOP)AdverseEventPhaseIVDataManagementMulticenterTrialClinicalStudyReport(CSR)ClinicalEndpointEndpointRecruitmentTargetProtocolInvestigatorMeetingClinicalResearchCoordinatorScreeningVisitSafetyProfileSourceDataVerificationTrialRegistryParallelStudyEthicsCommitteeDataLockPatientRecruitmentDouble-BlindStudySurrogateEndpointInformedConsentAuditTrailInstitutionalReviewBoard(IRB)CaseReportForm(CRF)PrincipalInvestigatorEfficacyFollow-up VisitDropoutRateData SafetyMonitoringBoard(DSMB)EligibilityCriteriaPilotStudyTrialMonitorAdaptiveDesignControlGroupStatisticalAnalysisPlan(SAP)GoodClinicalPractice(GCP)ProtocolDeviationPhaseIIIBlindingOpen-LabelTrialRegulatoryAuthorityPhaseIRandomizationSponsorCrossoverStudyPlaceboPhaseIIInterventionStandardOperatingProcedure(SOP)AdverseEventPhaseIVDataManagementMulticenterTrialClinicalStudyReport(CSR)ClinicalEndpointEndpointRecruitmentTargetProtocolInvestigatorMeetingClinicalResearchCoordinatorScreeningVisitSafetyProfileSourceDataVerificationTrialRegistryParallelStudyEthicsCommittee

Clinical Trials Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. Data Lock
  2. Patient Recruitment
  3. Double-Blind Study
  4. Surrogate Endpoint
  5. Informed Consent
  6. Audit Trail
  7. Institutional Review Board (IRB)
  8. Case Report Form (CRF)
  9. Principal Investigator
  10. Efficacy
  11. Follow-up Visit
  12. Dropout Rate
  13. Data Safety Monitoring Board (DSMB)
  14. Eligibility Criteria
  15. Pilot Study
  16. Trial Monitor
  17. Adaptive Design
  18. Control Group
  19. Statistical Analysis Plan (SAP)
  20. Good Clinical Practice (GCP)
  21. Protocol Deviation
  22. Phase III
  23. Blinding
  24. Open-Label Trial
  25. Regulatory Authority
  26. Phase I
  27. Randomization
  28. Sponsor
  29. Crossover Study
  30. Placebo
  31. Phase II
  32. Intervention
  33. Standard Operating Procedure (SOP)
  34. Adverse Event
  35. Phase IV
  36. Data Management
  37. Multicenter Trial
  38. Clinical Study Report (CSR)
  39. Clinical Endpoint
  40. Endpoint
  41. Recruitment Target
  42. Protocol
  43. Investigator Meeting
  44. Clinical Research Coordinator
  45. Screening Visit
  46. Safety Profile
  47. Source Data Verification
  48. Trial Registry
  49. Parallel Study
  50. Ethics Committee